- Stock: In Stock
- Brand: Incepta Pharmaceuticals
- Product ID: Budesonide
100% Secure Payment
Budicort 0.5 Nebuliser Susp.
Indications
Budicort nebuliser suspension is indicated for the maintenance treatment and as prophylactic therapy of asthma.
Dosage & Administration
Children 3 months to 12 years of age: 0.5 - 1 mg twice daily.
Adults and elderly: 1 - 2 mg twice daily.
Side Effects
Sneezing, headache, sore throat, dry mouth, nausea etc. have been reported as the common side effects.
Precautions
Budesonide nebuliser suspension should be used with caution in patients with active or quiescent tuberculous infection, untreated fungal, bacterial, or systemic viral infections, or ocular herpes simplex infection.
Use in Pregnancy & Lactation
Pregnancy: There are no adequate and well-controlled studies in pregnant women. Budesonide nebuliser suspension, like other corticosteroids, should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Lactation: It is not known whether Budesonide is excreted in human milk. Because other corticosteroids are excreted in human milk, caution should be exercised when Budesonide nebuliser suspension is administered to nursing women.
Drug Interaction
No significant drug interactions have been reported.
Commercial Pack
Budicort Nebuliser Suspension 0.5: Each box contains 5 ampoules of 2 ml.
